Cipla ropes in Dr Reddy's Umang Vohra as Global CFO
Mumbai : In a management rejig, drug major Cipla Ltd today appointed former head of Dr Reddy's North American business Umang Vohra as its Global Chief Financial and Strategy Officer.
While, former HR Head of Reliance Industries Prabir Jha is appointed as Global Chief People Officer.
These changes will be effective from October 1, the company said in a BSE filing.
Further the company said that Jha, in addition to providing leadership to the human resources function globally will lead the corporate communications and administration functions as well.
Commenting about the appointment of Vohra, Cipla Ltd MD and Global CEO Subhanu Saxena said, "He brings deep insights about the global generics industry as well as an understanding of value creation through his background in leading business and finance roles."
Prior to Dr Reddy's, Vohra worked with PepsiCo and Eicher Motors.
Samina Vaziralli, Executive Director who has been interim Head of HR said: "We truly believe focusing and building on human capital is one of the ultimate sources of sustainable, competitive advantage."
While, former HR Head of Reliance Industries Prabir Jha is appointed as Global Chief People Officer.
These changes will be effective from October 1, the company said in a BSE filing.
Further the company said that Jha, in addition to providing leadership to the human resources function globally will lead the corporate communications and administration functions as well.
Commenting about the appointment of Vohra, Cipla Ltd MD and Global CEO Subhanu Saxena said, "He brings deep insights about the global generics industry as well as an understanding of value creation through his background in leading business and finance roles."
Prior to Dr Reddy's, Vohra worked with PepsiCo and Eicher Motors.
Samina Vaziralli, Executive Director who has been interim Head of HR said: "We truly believe focusing and building on human capital is one of the ultimate sources of sustainable, competitive advantage."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.